Skip to content

Advertisement

Articles

Page 12 of 12

  1. Content type: Review

    Chordoma is a rare mesenchymal tumour of complex biology for which only histologic and immunohistochemical criteria have been defined, but no biomarkers predicting the clinical outcome and response to treatmen...

    Authors: Lidia Larizza, Pietro Mortini and Paola Riva

    Citation: Hereditary Cancer in Clinical Practice 2005 3:29

    Published on:

  2. Content type: Research

    A substantial minority of individuals who initially apply for genetic counselling for breast/ovarian cancer withdraw at an early stage from the counselling process. This study investigated the self-reported re...

    Authors: Eveline Bleiker, Gea Wigbout, Anja van Rens, Senno Verhoef, Laura van't Veer and Neil Aaronson

    Citation: Hereditary Cancer in Clinical Practice 2005 3:19

    Published on:

  3. Content type: Research

    The Swedish Family-Cancer Database has been used for almost 10 years in the study of familial risks at all common sites. In the present paper we describe some main features of version VI of this Database, asse...

    Authors: Kari Hemminki, Charlotta Granström and Bowang Chen

    Citation: Hereditary Cancer in Clinical Practice 2005 3:7

    Published on:

  4. Content type: Research

    To determine a cost-efficient strategy for HNPCC molecular diagnostic testing.

    Authors: Francesca Pigatto, Adrian Bateman, David Bunyan, Paul Strike, Esta Wilkins, Claire Curtis, Philippa Duncan, Denzil May, Karen Nugent and Diana Eccles

    Citation: Hereditary Cancer in Clinical Practice 2004 2:175

    Published on:

  5. Content type: Review

    Multiple Osteochondromas is an autosomal dominant disorder characterised by the presence of multiple osteochondromas and a variety of orthopaedic deformities. Two genes causative of Multiple Osteochondromas, Exos...

    Authors: Liesbeth Hameetman, Judith VMG Bovée, Antonie HM Taminiau, Herman M Kroon and Pancras CW Hogendoorn

    Citation: Hereditary Cancer in Clinical Practice 2004 2:161

    Published on:

  6. Content type: Research

    The known breast cancer susceptibility genes only account for 20% to 25% of the excess familial risk of the disease [1]. The present study assessed the contribution of BRCA1/2 mutations and CHEK2 variants to the ...

    Authors: Justo Lorenzo Bermejo, Alfonso García Pérez and Kari Hemminki

    Citation: Hereditary Cancer in Clinical Practice 2004 2:185

    Published on:

  7. Content type: Research

    To asses the retinal pigment epithelium (RPE) function measured by EOG testing in patients with neurofibromatosis type 1 (NF-1). Our preliminary EOG results suggested dysfunction of the RPE in individuals with...

    Authors: Wojciech Lubiński, Stanisław Zajączek, Zbigniew Sych, Krzysztof Penkala, Olgierd Palacz and Jan Lubiński

    Citation: Hereditary Cancer in Clinical Practice 2004 2:193

    Published on:

  8. Content type: Review

    Several studies have demonstrated that familial breast cancers associated with BRCA1 or BRCA2 germline mutations differ in their morphological and immunohistochemical characteristics. Cancers associated with BRCA...

    Authors: Emiliano Honrado, Javier Benítez and José Palacios

    Citation: Hereditary Cancer in Clinical Practice 2004 2:131

    Published on:

  9. Content type: Research

    To establish the contribution of TP53 germline mutations to familial breast/ovarian cancer in Germany we screened the complete coding region of the TP53 gene in a series of German breast/ovarian cancer families n...

    Authors: Xuan Liu, Hans-Peter Sinn, Hans Ulrich Ulmer, Rodney J Scott and Ute Hamann

    Citation: Hereditary Cancer in Clinical Practice 2004 2:139

    Published on:

  10. Content type: Review

    Prostate cancer is the most common cancer in men and the second highest cause of cancer-related mortality in the U.K. A genetic component in predisposition to prostate cancer has been recognized for decades. O...

    Authors: Sashi Kommu, Stephen Edwards and Rosalind Eeles

    Citation: Hereditary Cancer in Clinical Practice 2004 2:111

    Published on:

  11. Content type: Review

    Approximately 3-15% of all malignant melanomas (MM) are familial cases. MM is a highly heterogeneous tumour type from a genetic perspective. Pedigrees with disease confined to a single generation of siblings o...

    Authors: Tadeusz Dębniak

    Citation: Hereditary Cancer in Clinical Practice 2004 2:123

    Published on:

  12. Content type: Research

    We report three Dutch families with familial clustering of (pre)neoplastic cervical disease, review the literature on familial risks of cervical intraepithelial neoplasia (CIN) and cervical cancer, and discuss...

    Authors: Margreet Zoodsma, Rolf H Sijmons, Elisabeth GE de Vries and Ate GJ van der Zee

    Citation: Hereditary Cancer in Clinical Practice 2004 2:99

    Published on:

  13. Content type: Review

    Approximately 10% of gastric cancer cases show familial clustering but only 1-3% of gastric carcinomas arise as a result of inherited gastric cancer predisposition syndromes. Direct proof that Hereditary Gastr...

    Authors: Carla Oliveira, Gianpaolo Suriano, Paulo Ferreira, Paulo Canedo, Pardeep Kaurah, Rita Mateus, Ana Ferreira, António C Ferreira, Maria José Oliveira, Céu Figueiredo, Fátima Carneiro, Gisela Keller, David Huntsman, José Carlos Machado and Raquel Seruca

    Citation: Hereditary Cancer in Clinical Practice 2004 2:51

    Published on:

  14. Content type: Research

    Familial adenomatous polyposis (FAP) is characterized by the presence of hundreds to thousands of adenomas that carpet the entire colon and rectum. Nonsense and frameshift mutations in the adenomatous polyposi...

    Authors: Rodney J Scott, Renee Crooks, Lindy Rose, John Attia, Ammarin Thakkinstian, Lesley Thomas, Allan D Spigelman and Cliff J Meldrum

    Citation: Hereditary Cancer in Clinical Practice 2004 2:81

    Published on:

  15. Content type: Research

    To determine which individuals with colorectal cancer (CRC) were interested in knowing the results of their tumour microsatellite instability (MSI) and immunohistochemistry (IHC) testing. We were also interest...

    Authors: Noralane M Lindor, Jeff Sloan, Richard Goldberg, Deborah Bowen, Sandra Nigon, Amber Roche, Gloria Petersen, Stephen N Thibodeau, Laurence Burgart, Olga Leontovich and Bruce W Morlan

    Citation: Hereditary Cancer in Clinical Practice 2004 2:69

    Published on:

  16. Content type: Research

    Gastric cancer is the second most frequently diagnosed malignancy worldwide and therefore represents a significant healthcare burden. Environmental and genetic factors are involved in the development of gastri...

    Authors: Beata Gawdis-Wojnarska, Marek Brzosko, Jacek Fliciński, Krzysztof Marlicz, Teresa Starzyńska, Rodney J Scott and Jan Lubiński

    Citation: Hereditary Cancer in Clinical Practice 2004 2:65

    Published on:

  17. Content type: Short report

    Central nervous system hemangioblastomas (cHAB) are rare tumours which most commonly arise in the cerebellum. Most tumours are sporadic, but as many as one third of cHABs occur in the course of the hereditary ...

    Authors: Cezary Cybulski, Joanna Matyjasik, Marianna Soroka, Janusz Szymaś, Bohdan Górski, Tadeusz Dębniak, Anna Jakubowska, Andrzej Bernaczyk, Lech Zimnoch, Grażyna Bierzyńska-Macyszyn, Tomasz Trojanowski, Teresa Wierzba-Bobrowicz, Edmund Prudlak, Alicja Markowska-Wojciechowska, Przemysław Nowacki, Andrzej Roszkiewicz…

    Citation: Hereditary Cancer in Clinical Practice 2004 2:93

    Published on:

  18. Content type: Review

    There is much debate in the literature about familial predispositions to breast and bowel cancers yet little evidence is forthcoming to suggest that there are susceptibility genes that can account for such kin...

    Authors: Rodney J Scott and Katie A Ashton

    Citation: Hereditary Cancer in Clinical Practice 2004 2:25

    Published on:

  19. Content type: Review

    When BRCA1/2 genetic susceptibility testing was introduced in the clinic in the mid-nineties, the "Huntington protocol" was used in the counselling of individuals applying for genetic testing. This protocol inclu...

    Authors: Iris van Oostrom and Aad Tibben

    Citation: Hereditary Cancer in Clinical Practice 2004 2:19

    Published on:

  20. Content type: Case report

    This paper highlights the need for carriers to be followed up by health professionals who understand the complexities of the BRCA syndrome. A BRCA carrier clinic has been established in London and regular follow ...

    Authors: Audrey Ardern-Jones and Rosalind Eeles

    Citation: Hereditary Cancer in Clinical Practice 2004 2:77

    Published on:

  21. Content type: Research

    Denaturing high performance liquid chromatography is a relatively new method by which heteroduplex structures formed during the PCR amplification of heterozygote samples can be rapidly identified. The use of t...

    Authors: Cliff J. Meldrum, Mary McPhillips, Renee Crooks, Lesley Thomas, Ted Edkins, Rohanna Creegan, Ewan Miller, Michael Agrez and Rodney J. Scott

    Citation: Hereditary Cancer in Clinical Practice 2003 1:39

    Published on:

  22. Content type: Review

    HNPCC (Lynch syndrome) is the most common form of hereditary colorectal cancer (CRC), wherein it accounts for between 2-7 percent of the total CRC burden. When considering the large number of extracolonic canc...

    Authors: Henry T. Lynch, Jane F. Lynch, Trudy G. Shaw and Jan Lubiński

    Citation: Hereditary Cancer in Clinical Practice 2003 1:7

    Published on:

  23. Content type: Research

    The criteria for the diagnosis of HNPCC established by the ICG-HNPCC are very restrictive as they do not allow for the diagnosis of a large number of "suspected HNPCC" cases - these are families which do no fu...

    Authors: Józef Kładny, Gabriela Möslein, Torben Myrhøj, Grzegorz Kurzawski, Anna Jakubowska, Tadeusz Dębniak, Wojciech Petriczko, Michał Kozłowski, Tariq Al-Amawi, Marek Brzosko, Jacek Fliciński, Arkadiusz Jawień, Zbigniew Banaszkiewicz, Piotr Rychter and Jan Lubiński

    Citation: Hereditary Cancer in Clinical Practice 2003 1:34

    Published on:

  24. Content type: Research

    The aim of the study is to evaluate the incidence and phenotype - genotype characteristics of hereditary colorectal cancer syndromes in Latvia in order to develop the basis of clinical management for patients ...

    Authors: Arvids Irmejs, Andris Gardovskis, Viktors Borosenko, Marianna Bitina, Diana Aigare, Grzegorz Kurzawski, Janina Suchy, Bohdan Górski and Janis Gardovskis

    Citation: Hereditary Cancer in Clinical Practice 2003 1:49

    Published on:

  25. Content type: Commentary

    In addition to a relatively small number of well known hereditary cancer syndromes, hundreds of presumed or proven hereditary disorders have been observed to manifest cancer as a characteristic feature or as a...

    Authors: Rolf H. Sijmons and Gerard T.N. Burger

    Citation: Hereditary Cancer in Clinical Practice 2003 1:31

    Published on:

2017 Journal Metrics

Advertisement